[
    [
        {
            "time": "",
            "original_text": "医药生物行业简评报告：康泰13价肺炎疫苗获批 长期看好疫苗龙头",
            "features": {
                "keywords": [
                    "康泰",
                    "13价肺炎疫苗",
                    "获批",
                    "疫苗龙头"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业简评报告：康泰13价肺炎疫苗获批 长期看好疫苗龙头",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "卓胜微、康泰生物跌超5%，双创基金ETF（159783）跌幅扩大",
            "features": {
                "keywords": [
                    "卓胜微",
                    "康泰生物",
                    "双创基金ETF",
                    "跌幅"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "卓胜微、康泰生物跌超5%，双创基金ETF（159783）跌幅扩大",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "康泰生物、沃森生物、乐普医疗跌超4%，科创创业ETF（588360）跌超1%",
            "features": {
                "keywords": [
                    "康泰生物",
                    "沃森生物",
                    "乐普医疗",
                    "科创创业ETF",
                    "跌幅"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物、沃森生物、乐普医疗跌超4%，科创创业ETF（588360）跌超1%",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]